Page 12 - Viral Vector News Today

Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2022: By Gene, By Vector, By Application, By End-User" report has been...

In a recent study published in the journal Nature Medicine, researchers assessed the coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) against symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs) by genetic mismatch/distance (GD) analysis.

The mysterious hepatitis targeting children continues to wreak havoc around the world. Hundreds of cases worldwide have been confirmed by investigators and more American states have been [...]

JERSEY CITY, N.J., June 14, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Viral and Non-Viral Vector Manufacturing Market

Toronto, ON (PRWEB) June 13, 2022 -- Osmolality, a measure of solute concentration, can have many applications throughout the entirety of the cell and gene

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

Viral and Non-Viral Vector Manufacturing Market Size, Growth, Demand, Trends, Analysis and Forecast Report by 2027

Toronto, ON (PRWEB) June 01, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical

Scientists at La Jolla Institute for Immunology have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2.